Article Information
- Received March 29, 2017
- Revision received September 20, 2017
- Accepted September 27, 2017
- First published October 5, 2017.
- Version of record published November 8, 2017.
Author Information
Author contributions
Author contributions: Y.-J.S. designed research; S.B.H., H.K., and H.L. performed research; G.M.S. contributed unpublished reagents/analytic tools; S.B.H., H.K., H.L., M.G., G.M.S., and Y.-J.S. analyzed data; S.B.H. and Y.-J.S. wrote the paper.
Disclosures
- Received March 29, 2017.
- Revision received September 20, 2017.
- Accepted September 27, 2017.
This work was supported by Shriners Hospitals for Children and NIH NINDS (NS079631 and NS095070 to Y.-J.S.) and Neural Repair Viral Core (G.M.S.). We thank Alan Tessler and members of the Son laboratory for critical reading of the paper; Dr. Wes Thompson for S100-rtTA;tetO-Neu-NT line; Dr. Stephen Strittmatter for SPRR1A antibody; and Drs. Christopher Hayworth, Shuxin Li, Mary Barbe, Gareth Thomas, and Seonhee Kim for sharing resources and technical help.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Young-Jin Son, Temple University School of Medicine, MERB, 6th Floor, 3500 North Broad Street, Philadelphia, PA 19140. yson{at}temple.edu
Other Version
- previous version (October 05, 2017).
- You are viewing the most recent version of this article.
Online Impact